The treatment of monoclonal Ig deposition disease (MIDD) is controversial and not standardized. We report our experience with high dose melphalan and auto-SCT (HDM/auto-SCT) in seven patients with ...

Melphalan is a chemotherapy agent, prescribed for multiple myeloma, melanoma, and ovarian carcinoma. The risk or severity of adverse effects can be increased when Melphalan is combined with Bacillus ...

Melphalan hydrochloride belongs to a group of drugs called alkylating drugs. It’s available as a powder that is mixed into a solution for injection. It’s given as an intravenous (IV) infusion (an ...

Oral melphalan and dexamethasone (MDex) is a standard treatment for patients with AL amyloidosis who are not eligible for stem cell transplantation at many referral centers. However, following ...

June 10, 2009 — The FDA this month approved orphan drug designation for melphalan infusion (Delcath Systems, Inc) in the treatment of patients with neuroendocrine tumors metastatic to the liver. The ...

Discover comprehensive details about Melphalan, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte. Resistance to alkylating ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Dr Samur and colleagues found that high-dose melphalan caused an approximately 2.5-fold greater mutation accumulation rate than that observed with RVD treatment alone. Treatment with high-dose ...

COVID-19 and Cancer Care: Ensuring Safety While Transforming Care Delivery This was a phase III, multicenter, randomized, open-label trial. Patients were stratified according to cardiac stage.

The standard treatment for patients with multiple myeloma who are not candidates for high-dose therapy is melphalan and prednisone. This phase 3 study compared the use of melphalan and prednisone with ...

WESTON, Fla., May 9, 2025 /PRNewswire/ - Apotex Corp. today launched IVRA™ (Melphalan) hydrochloride injection 90mg/ml multidose vial ("IVRA"), first ready-to-dilute liquid formulation of Melphalan ...